Psoriasis Drugs Market Size And Share

  • Report Code : TIPRE00004962
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Marktgröße und Marktanteil von Psoriasis-Medikamenten bis 2025 – 2031

Buy Now

Psoriasis Drugs Market Report Psoriasis Drugs Market Scope and Analysis Psoriasis Drugs Market Size and Share

Psoriasis Drugs Market Report Analysis

Psoriasis Drugs Market

  • CAGR (2025 - 2031)
    10.5%
  • Market Size 2024
    US$ XX million
  • Market Size 2031
    US$ XX Million

Report Coverage

  • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Key future trends
  • Detailed PEST/Porter’s Five Forces and SWOT analysis
  • Industry landscape and competition analysis & recent developments
  • Detailed company profiles
  • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

  • AbbVie Inc.
  • Amgen Inc.
  • AstraZeneca
  • CELGENE CORPORATION
  • Eli Lilly and Company
  • Johnson & Johnson Services, Inc.
  • Merck & Co., Inc.
  • Novartis Pharmaceuticals Corporation
  • Pfizer Inc.

Regional Overview

  • Nordamerika
  • Europa
  • Asien-Pazifik
  • Süd- und Mittelamerika
  • Naher Osten und Afrika

Market Segmentation

By Therapeutische Klasse
  • Vitamin-D-Analoga
  • Interleukin-Inhibitoren
  • Tumornekrosefaktor-Inhibitoren
  • andere therapeutische Klasse
By Behandlung
  • topische
  • systemische und biologische Mittel
By Geographie
  • Nordamerika
  • Europa
  • Asien-Pazifik
  • Süd- und Mittelamerika
  • Naher Osten und Afrika